Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Athira Pharma Inc
ATHACurrent price
0.24 USD
+0.0027 USD (+1.14%)
Last closed
0.25 USD
Company
www.athira.com
ISIN
US04746L1044
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
9 331 133 USD
Yield for 12 month
-88.56 %
1Y
3Y
5Y
10Y
15Y
ATHA
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington. Address: 18706 North Creek Parkway, Bothell, WA, United States, 98011
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.55 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-969 000 USD
Current Quarter
–
Last Quarter
–
Key Figures ATHA
1 year
3 years
5 years
10 years
EBITDA
-95 805 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-55.23 %
PEG Ratio
–
Return On Equity TTM
-110.77 %
Wall Street Target Price
0.55 USD
Revenue TTM
–
Book Value
1.15 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.52 USD
Diluted Eps TTM
-2.52 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ATHA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ATHA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation ATHA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
1.31
Price Book MRQ
0.21
Financials ATHA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ATHA
For 52 weeks
0.22 USD
3.67 USD
50 Day MA
0.35 USD
Shares Short Prior Month
1 040 971
200 Day MA
1.07 USD
Short Ratio
4.58
Shares Short
934 467
Short Percent
3.38 %
BeatStart